SELLAS Life Sciences GAAP EPS of -$0.50 beats by $0.04
Source: SeekingAlpha
2025-03-20 16:37:53 ET
More on SELLAS Life Sciences
- SELLAS Life Sciences Group reports positive results from mid-stage lymphoma treatment trial
- SELLAS Life Sciences falls after data for blood cancer therapy
- Seeking Alpha’s Quant Rating on SELLAS Life Sciences
- Historical earnings data for SELLAS Life Sciences
- Financial information for SELLAS Life Sciences
Read the full article on Seeking Alpha
For further details see:
SELLAS Life Sciences GAAP EPS of -$0.50 beats by $0.04
SELLAS Life Sciences Group Inc.
NASDAQ: SLS
SLS Trading
20.38% G/L:
$6.97 Last:
7,820,479 Volume:
$6.48 Open:
SLS Latest News
May 12, 2026 04:05:00 pm
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
March 19, 2026 04:05:00 pm
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
SLS Stock Data
$535,597,063
140,448,048
1.12%
50
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
